Does CARMUSTINE Cause Diffuse large b-cell lymphoma refractory? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Diffuse large b-cell lymphoma refractory have been filed in association with CARMUSTINE (carmustine). This represents 0.2% of all adverse event reports for CARMUSTINE.
8
Reports of Diffuse large b-cell lymphoma refractory with CARMUSTINE
0.2%
of all CARMUSTINE reports
4
Deaths
3
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From CARMUSTINE?
Of the 8 reports, 4 (50.0%) resulted in death, 3 (37.5%) required hospitalization, and 3 (37.5%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Myelodysplastic syndrome (295)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Second primary malignancy (141)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which CARMUSTINE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB